Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Drug Resistant Depression - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Dr. Elizabeth Livengood’s presentation is on identifying different causes of depression, identifying depression, hyperthyroidism connections, identifying patient profiles who fit these descriptions, and understanding how to treat them. 

Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Rheumatoid Arthritis Case Study (2017 Conference) (LDN, low dose naltrexone)

Etiology of rheumatoid arthritis (RA) is autoimmune; has an inflammatory component including food sensitivities. Low Vitamin D a component, as in many diseases. LDN in two cases of RA.

Jill Brook, MA - What the Bleep Can I Eat?! Making Sense of Conflicting Autoimmune Diets (2017 Conference) (LDN, low dose naltrexone)

Jill Brook, MA - Intermittent Fasting (2019 Conference) (LDN, low dose naltrexone)

Jill Brook MA – Fasting and Autoimmunity: New Promising Findings

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD, MS - Traumatic Brain Injury: Low Dose Naltrexone and Microglial Modification (2019 Conference) (LDN, low dose naltrexone)

Pamela Smith, MD - LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis (2019 Conference) (LDN, low dose naltrexone)

Pamela Smith, MD - LDN and Multiple Sclerosis (2019 Conference) (LDN, low dose naltrexone)